_id
6915f7edbc934aba376b2526
Ticker
SHEZF
Name
Shenzhen Hepalink Pharmaceutical Group Co. Ltd
Exchange
PINK
Address
No. 21 Langshan Road, Shenzhen, China, 518057
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.hepalink.com
Description
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. provides pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. It operates in four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization (CDMO), and Others. The company offers finished dose pharmaceutical products, such as prolongin, inhixa, neoparin, and heparin and enoxaparin sodium injections; API products, including heparin and enoxaparin sodium APIs; and pancreatin API. It also provides molecule biologics CDMO services, which include research and development, manufacturing, quality management, and program management services, as well as technical support services. In addition, the company develops apabetalone (RVX-208), a BET bromodomain protein inhibitor in Phase 3 trial to reduce major adverse cardiovascular events, as well as in Phase 2 trial for diabetic nephropathy and fatty disease; oregovomab, a monoclonal antibody in Phase 3 trial for ovarian cancer, as well as in Phase 2 for pancreatic cancer; tosatoxumab (AR-301), a fully human IgG1 monoclonal antibody in Phase 3 trial for ventilator-associated pneumonia; AR20.5 in Phase 2 trial for pancreatic cancer; AR-101 in Phase 2 trial for ventilator-associated pneumonia; and H1710, a heparanase inhibitor preparation for solid tumors. Further, it engages in property management, investment management and consulting, biopharmaceutical technology development and consulting, and equity and venture investment activities; provision of services on pharmaceutical related activities; and trading of medical and biopharmaceutical products. The company was formerly known as Shenzhen Hepalink Pharmaceutical Co.,Ltd. and changed its name to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in February 2017. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, the People's Republic of China.
Last Close
0.4696
Volume
-
Current Price
0.4696
Change
0
Last Updated
2026-01-07T11:41:36.153Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
1057333696
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
1423097121
Cost Of Revenue
926289855
Gross Profit
496807266
Operating Expenses
191529319
Operating Income
305277946
Interest Expense
17528946
Pretax Income
305402931
Net Income
265260304
Eps
0.18074743182986333
Dividends Per Share
22025312
Shares Outstanding
220094500
Income Tax Expense
40392166
EBITDA
322931877
Operating Margin
21.45165930667356
Total Other Income Expense Net
124984
Cash
2175661808
Short Term Investments
886810206
Receivables
1497951621
Inventories
4670336436
Total Current Assets
9514212490
Property Plant Equipment
2594877372
Total Assets
17234973396
Payables
364791862
Short Term Debt
1801106128
Long Term Debt
528171376.28
Total Liabilities
5023001066
Equity
12159207711
Bs_currency_symbol
CNY
Depreciation
-
Change In Working Capital
-
Cash From Operations
504776413
Capital Expenditures
39948952
Cash From Investing
28414125
Cash From Financing
-526925322
Net Change In Cash
4234386
Cf_currency_symbol
CNY
PE
-
PB
0.05667909909015947
ROE
2.181559113921777
ROA
1.5390815982435069
FCF
464827461
Fcf Percent
0.32663087721895545
Piotroski FScore
4
Health Score
72
Deep Value Investing Score
10
Defensive Investing Score
7
Dividend Investing Score
3.5
Economic Moat Investing Score
7.8
Garp Investing Score
6.5
Growth Investing Score
5
Momentum Investing Score
3.5
Net Net Investing Score
8
Quality Investing Score
8
Value Investing Score
8.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1423097121
Quarters > 0 > income Statement > cost Of Revenue
926289855
Quarters > 0 > income Statement > gross Profit
496807266
Quarters > 0 > income Statement > operating Expenses
191529319
Quarters > 0 > income Statement > operating Income
305277946
Quarters > 0 > income Statement > interest Expense
17528946
Quarters > 0 > income Statement > pretax Income
305402931
Quarters > 0 > income Statement > net Income
265260304
Quarters > 0 > income Statement > eps
0.18074743182986333
Quarters > 0 > income Statement > dividends Per Share
22025312
Quarters > 0 > income Statement > shares Outstanding
1467574401
Quarters > 0 > income Statement > income Tax Expense
40392166
Quarters > 0 > income Statement > EBITDA
322931877
Quarters > 0 > income Statement > operating Margin
21.45165930667356
Quarters > 0 > income Statement > total Other Income Expense Net
124984
Quarters > 0 > income Statement > currency_symbol
CNY
Quarters > 0 > balance Sheet > cash
2175661808
Quarters > 0 > balance Sheet > short Term Investments
886810206
Quarters > 0 > balance Sheet > receivables
1497951621
Quarters > 0 > balance Sheet > inventories
4670336436
Quarters > 0 > balance Sheet > total Current Assets
9514212490
Quarters > 0 > balance Sheet > property Plant Equipment
2594877372
Quarters > 0 > balance Sheet > total Assets
17234973396
Quarters > 0 > balance Sheet > payables
364791862
Quarters > 0 > balance Sheet > short Term Debt
1801106128
Quarters > 0 > balance Sheet > long Term Debt
528171376.28
Quarters > 0 > balance Sheet > total Liabilities
5023001066
Quarters > 0 > balance Sheet > equity
12159207711
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
265260304.52
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
504776413
Quarters > 0 > cash Flow > capital Expenditures
39948952
Quarters > 0 > cash Flow > cash From Investing
28414125
Quarters > 0 > cash Flow > cash From Financing
-526925322
Quarters > 0 > cash Flow > net Change In Cash
4234386
Quarters > 0 > cash Flow > currency_symbol
CNY
Quarters > 0 > ratios > PE
0.18074743182986333
Quarters > 0 > ratios > PB
0.05667909909015947
Quarters > 0 > ratios > ROE
2.181559113921777
Quarters > 0 > ratios > ROA
1.5390815982435069
Quarters > 0 > ratios > FCF
464827461
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.32663087721895545
Quarters > 0 > health Score
72
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
1394250050
Quarters > 1 > income Statement > cost Of Revenue
1013068235
Quarters > 1 > income Statement > gross Profit
381181815
Quarters > 1 > income Statement > operating Expenses
202201472
Quarters > 1 > income Statement > operating Income
178980342
Quarters > 1 > income Statement > interest Expense
22447163
Quarters > 1 > income Statement > pretax Income
178239293
Quarters > 1 > income Statement > net Income
156590188
Quarters > 1 > income Statement > eps
0.1066999996002247
Quarters > 1 > income Statement > dividends Per Share
24391010
Quarters > 1 > income Statement > shares Outstanding
1467574401
Quarters > 1 > income Statement > income Tax Expense
22070103
Quarters > 1 > income Statement > EBITDA
200686456
Quarters > 1 > income Statement > operating Margin
12.83703321366207
Quarters > 1 > income Statement > total Other Income Expense Net
-741049
Quarters > 1 > income Statement > currency_symbol
CNY
Quarters > 1 > balance Sheet > cash
2000842827
Quarters > 1 > balance Sheet > short Term Investments
1101058946
Quarters > 1 > balance Sheet > receivables
1482232245
Quarters > 1 > balance Sheet > inventories
4952734323
Quarters > 1 > balance Sheet > total Current Assets
9873944183
Quarters > 1 > balance Sheet > property Plant Equipment
2622871487
Quarters > 1 > balance Sheet > total Assets
17545801889
Quarters > 1 > balance Sheet > payables
316197260
Quarters > 1 > balance Sheet > short Term Debt
1819531746
Quarters > 1 > balance Sheet > long Term Debt
979890255.35
Quarters > 1 > balance Sheet > total Liabilities
5205766284
Quarters > 1 > balance Sheet > equity
12287013000
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
156590188
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
544031931
Quarters > 1 > cash Flow > capital Expenditures
41013022.8
Quarters > 1 > cash Flow > cash From Investing
-257551999
Quarters > 1 > cash Flow > cash From Financing
22602544
Quarters > 1 > cash Flow > net Change In Cash
318638044
Quarters > 1 > cash Flow > currency_symbol
CNY
Quarters > 1 > ratios > PE
0.1066999996002247
Quarters > 1 > ratios > PB
0.05608954256901983
Quarters > 1 > ratios > ROE
1.2744365778729134
Quarters > 1 > ratios > ROA
0.8924652688468527
Quarters > 1 > ratios > FCF
503018908.2
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.3607809863087328
Quarters > 1 > health Score
70
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
1211789363
Quarters > 2 > income Statement > cost Of Revenue
806633072
Quarters > 2 > income Statement > gross Profit
405156291
Quarters > 2 > income Statement > operating Expenses
567323061
Quarters > 2 > income Statement > operating Income
-162166770.44
Quarters > 2 > income Statement > interest Expense
30637770
Quarters > 2 > income Statement > pretax Income
-160973516.16
Quarters > 2 > income Statement > net Income
-133372145.5
Quarters > 2 > income Statement > eps
-0.09089653822889601
Quarters > 2 > income Statement > dividends Per Share
26660805.52
Quarters > 2 > income Statement > shares Outstanding
1467296204
Quarters > 2 > income Statement > income Tax Expense
-6832264.03
Quarters > 2 > income Statement > EBITDA
-130335745.32
Quarters > 2 > income Statement > operating Margin
-13.38242234100218
Quarters > 2 > income Statement > total Other Income Expense Net
1193254
Quarters > 2 > income Statement > currency_symbol
CNY
Quarters > 2 > balance Sheet > cash
1689041495
Quarters > 2 > balance Sheet > short Term Investments
868416630
Quarters > 2 > balance Sheet > receivables
1277844378
Quarters > 2 > balance Sheet > inventories
5393947174
Quarters > 2 > balance Sheet > total Current Assets
9621274306
Quarters > 2 > balance Sheet > property Plant Equipment
2647675241
Quarters > 2 > balance Sheet > total Assets
17343523964
Quarters > 2 > balance Sheet > payables
299691922
Quarters > 2 > balance Sheet > short Term Debt
1838944224
Quarters > 2 > balance Sheet > long Term Debt
1081047955.83
Quarters > 2 > balance Sheet > total Liabilities
5141403413
Quarters > 2 > balance Sheet > equity
12148672778
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
-133372145.5
Quarters > 2 > cash Flow > depreciation
31831025
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
62494598.83
Quarters > 2 > cash Flow > cash From Investing
-188826326.4
Quarters > 2 > cash Flow > cash From Financing
-793775405.29
Quarters > 2 > cash Flow > net Change In Cash
-573652365.39
Quarters > 2 > cash Flow > currency_symbol
CNY
Quarters > 2 > ratios > PE
-0.09089653822889601
Quarters > 2 > ratios > PB
0.05671749581124491
Quarters > 2 > ratios > ROE
-1.0978330549944788
Quarters > 2 > ratios > ROA
-0.7690025728153109
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
1231523140
Quarters > 3 > income Statement > cost Of Revenue
868779925
Quarters > 3 > income Statement > gross Profit
362743215
Quarters > 3 > income Statement > operating Expenses
242607133
Quarters > 3 > income Statement > operating Income
120136081
Quarters > 3 > income Statement > interest Expense
30989695
Quarters > 3 > income Statement > pretax Income
119553776
Quarters > 3 > income Statement > net Income
116430360
Quarters > 3 > income Statement > eps
0.07935027684430648
Quarters > 3 > income Statement > dividends Per Share
39405907.71
Quarters > 3 > income Statement > shares Outstanding
1467296204
Quarters > 3 > income Statement > income Tax Expense
3330176
Quarters > 3 > income Statement > EBITDA
180950863
Quarters > 3 > income Statement > operating Margin
9.755081094131938
Quarters > 3 > income Statement > total Other Income Expense Net
-582305
Quarters > 3 > income Statement > currency_symbol
CNY
Quarters > 3 > balance Sheet > cash
2242888528
Quarters > 3 > balance Sheet > short Term Investments
836795932
Quarters > 3 > balance Sheet > receivables
1301778341
Quarters > 3 > balance Sheet > inventories
5612822105
Quarters > 3 > balance Sheet > total Current Assets
10371982696
Quarters > 3 > balance Sheet > property Plant Equipment
2633168900
Quarters > 3 > balance Sheet > total Assets
18121417326
Quarters > 3 > balance Sheet > payables
343997903
Quarters > 3 > balance Sheet > short Term Debt
1943995355
Quarters > 3 > balance Sheet > long Term Debt
1192542910.05
Quarters > 3 > balance Sheet > total Liabilities
5906888588
Quarters > 3 > balance Sheet > equity
12140384965
Quarters > 3 > balance Sheet > currency_symbol
CNY
Quarters > 3 > cash Flow > net Income
116430360.57
Quarters > 3 > cash Flow > depreciation
30407391
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
52927313.24
Quarters > 3 > cash Flow > cash From Investing
-386285043.58
Quarters > 3 > cash Flow > cash From Financing
-317130859.14
Quarters > 3 > cash Flow > net Change In Cash
-207238434.55
Quarters > 3 > cash Flow > currency_symbol
CNY
Quarters > 3 > ratios > PE
0.07935027684430648
Quarters > 3 > ratios > PB
0.0567562148469647
Quarters > 3 > ratios > ROE
0.959033509527595
Quarters > 3 > ratios > ROA
0.6425013998929854
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
58
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
5280713410
Annuals > 0 > income Statement > cost Of Revenue
3524558247
Annuals > 0 > income Statement > gross Profit
1756155163
Annuals > 0 > income Statement > operating Expenses
1014844187
Annuals > 0 > income Statement > operating Income
741310975
Annuals > 0 > income Statement > interest Expense
141184426
Annuals > 0 > income Statement > pretax Income
726229257
Annuals > 0 > income Statement > net Income
646741666
Annuals > 0 > income Statement > eps
0.44079999962486366
Annuals > 0 > income Statement > dividends Per Share
159901320
Annuals > 0 > income Statement > shares Outstanding
1467199788
Annuals > 0 > income Statement > income Tax Expense
101311222
Annuals > 0 > income Statement > EBITDA
1198464859
Annuals > 0 > income Statement > operating Margin
14.038083823980896
Annuals > 0 > income Statement > total Other Income Expense Net
-15081718
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
1689041495
Annuals > 0 > balance Sheet > short Term Investments
868416630
Annuals > 0 > balance Sheet > receivables
1277844378
Annuals > 0 > balance Sheet > inventories
5393947174
Annuals > 0 > balance Sheet > total Current Assets
9621274306
Annuals > 0 > balance Sheet > property Plant Equipment
2647675241
Annuals > 0 > balance Sheet > total Assets
17343523964
Annuals > 0 > balance Sheet > payables
299691922
Annuals > 0 > balance Sheet > short Term Debt
1838944224
Annuals > 0 > balance Sheet > long Term Debt
1081047955.83
Annuals > 0 > balance Sheet > total Liabilities
5141403413
Annuals > 0 > balance Sheet > equity
12148672778
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
624918035
Annuals > 0 > cash Flow > depreciation
331051175
Annuals > 0 > cash Flow > change In Working Capital
1203345050
Annuals > 0 > cash Flow > cash From Operations
2194132237
Annuals > 0 > cash Flow > capital Expenditures
202769168.7
Annuals > 0 > cash Flow > cash From Investing
-415048186
Annuals > 0 > cash Flow > cash From Financing
-2139730075
Annuals > 0 > cash Flow > net Change In Cash
-343817878
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
0.44079999962486366
Annuals > 0 > ratios > PB
0.05671376890589258
Annuals > 0 > ratios > ROE
5.32355820111628
Annuals > 0 > ratios > ROA
3.7290095562034766
Annuals > 0 > ratios > FCF
1991363068.3
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.3771011440478835
Annuals > 0 > health Score
75
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
5445572060
Annuals > 1 > income Statement > cost Of Revenue
4500648583
Annuals > 1 > income Statement > gross Profit
944923477
Annuals > 1 > income Statement > operating Expenses
1805834371
Annuals > 1 > income Statement > operating Income
-860910894
Annuals > 1 > income Statement > interest Expense
223219338
Annuals > 1 > income Statement > pretax Income
-928333834.54
Annuals > 1 > income Statement > net Income
-783258039.42
Annuals > 1 > income Statement > eps
-0.5338104448745646
Annuals > 1 > income Statement > dividends Per Share
425889625
Annuals > 1 > income Statement > shares Outstanding
1467296204
Annuals > 1 > income Statement > income Tax Expense
-126174604.92
Annuals > 1 > income Statement > EBITDA
-320447091.5
Annuals > 1 > income Statement > operating Margin
-15.809374745469809
Annuals > 1 > income Statement > total Other Income Expense Net
-67422940.54
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
1851642224
Annuals > 1 > balance Sheet > short Term Investments
414183796
Annuals > 1 > balance Sheet > receivables
1274530402
Annuals > 1 > balance Sheet > inventories
6654110786
Annuals > 1 > balance Sheet > total Current Assets
10603904524
Annuals > 1 > balance Sheet > property Plant Equipment
2634224775
Annuals > 1 > balance Sheet > total Assets
19203415131
Annuals > 1 > balance Sheet > payables
302222539
Annuals > 1 > balance Sheet > short Term Debt
1880741215
Annuals > 1 > balance Sheet > long Term Debt
1810021034.38
Annuals > 1 > balance Sheet > total Liabilities
7215037414
Annuals > 1 > balance Sheet > equity
11913149195
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
-802159229.62
Annuals > 1 > cash Flow > depreciation
373596020
Annuals > 1 > cash Flow > change In Working Capital
-800681898.6
Annuals > 1 > cash Flow > cash From Operations
398215676
Annuals > 1 > cash Flow > capital Expenditures
444877658
Annuals > 1 > cash Flow > cash From Investing
1221569303
Annuals > 1 > cash Flow > cash From Financing
-1210172083
Annuals > 1 > cash Flow > net Change In Cash
445937526
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
-0.5338104448745646
Annuals > 1 > ratios > PB
0.0578388036714586
Annuals > 1 > ratios > ROE
-6.5747354171366945
Annuals > 1 > ratios > ROA
-4.0787434634769175
Annuals > 1 > ratios > FCF
-46661982
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
-0.008568793413414127
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
7159410684
Annuals > 2 > income Statement > cost Of Revenue
4825009752
Annuals > 2 > income Statement > gross Profit
2334400932
Annuals > 2 > income Statement > operating Expenses
1211852274
Annuals > 2 > income Statement > operating Income
828623184
Annuals > 2 > income Statement > interest Expense
235242067
Annuals > 2 > income Statement > pretax Income
829850958
Annuals > 2 > income Statement > net Income
727425654
Annuals > 2 > income Statement > eps
0.49575924207870437
Annuals > 2 > income Statement > dividends Per Share
51355367
Annuals > 2 > income Statement > shares Outstanding
1467296204
Annuals > 2 > income Statement > income Tax Expense
115163747
Annuals > 2 > income Statement > EBITDA
1383292139
Annuals > 2 > income Statement > operating Margin
11.57390210694051
Annuals > 2 > income Statement > total Other Income Expense Net
1227779
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
2138779146
Annuals > 2 > balance Sheet > short Term Investments
1311642406
Annuals > 2 > balance Sheet > receivables
1625963973
Annuals > 2 > balance Sheet > inventories
6843906474
Annuals > 2 > balance Sheet > total Current Assets
12389647370
Annuals > 2 > balance Sheet > property Plant Equipment
2477289354
Annuals > 2 > balance Sheet > total Assets
20814206782
Annuals > 2 > balance Sheet > payables
427433123
Annuals > 2 > balance Sheet > short Term Debt
4056474055
Annuals > 2 > balance Sheet > long Term Debt
2296679910.52
Annuals > 2 > balance Sheet > total Liabilities
8406564448
Annuals > 2 > balance Sheet > equity
12310918546
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
714687211
Annuals > 2 > cash Flow > depreciation
307659455
Annuals > 2 > cash Flow > change In Working Capital
-2311251190.63
Annuals > 2 > cash Flow > cash From Operations
-756612526.02
Annuals > 2 > cash Flow > capital Expenditures
222421477.2
Annuals > 2 > cash Flow > cash From Investing
249839601
Annuals > 2 > cash Flow > cash From Financing
329564162
Annuals > 2 > cash Flow > net Change In Cash
-159926249
Annuals > 2 > cash Flow > currency_symbol
CNY
Annuals > 2 > ratios > PE
0.49575924207870437
Annuals > 2 > ratios > PB
0.05597001513930738
Annuals > 2 > ratios > ROE
5.908784558048687
Annuals > 2 > ratios > ROA
3.4948516732767034
Annuals > 2 > ratios > FCF
-979034003.22
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-0.13674784789311858
Annuals > 2 > health Score
52
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
6365177483
Annuals > 3 > income Statement > cost Of Revenue
4332138395
Annuals > 3 > income Statement > gross Profit
2033039088
Annuals > 3 > income Statement > operating Expenses
1068874395
Annuals > 3 > income Statement > operating Income
227474697
Annuals > 3 > income Statement > interest Expense
201630986
Annuals > 3 > income Statement > pretax Income
222262937
Annuals > 3 > income Statement > net Income
240787578
Annuals > 3 > income Statement > eps
0.164102910743985
Annuals > 3 > income Statement > dividends Per Share
220094430
Annuals > 3 > income Statement > shares Outstanding
1467296204
Annuals > 3 > income Statement > income Tax Expense
-11120488.05
Annuals > 3 > income Statement > EBITDA
731273790
Annuals > 3 > income Statement > operating Margin
3.573736908476398
Annuals > 3 > income Statement > total Other Income Expense Net
-5211760
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2944257086
Annuals > 3 > balance Sheet > short Term Investments
981157143
Annuals > 3 > balance Sheet > receivables
1543447061
Annuals > 3 > balance Sheet > inventories
4707548592
Annuals > 3 > balance Sheet > total Current Assets
10769653462
Annuals > 3 > balance Sheet > property Plant Equipment
2537156509
Annuals > 3 > balance Sheet > total Assets
19108175266
Annuals > 3 > balance Sheet > payables
385786645
Annuals > 3 > balance Sheet > short Term Debt
1886284700
Annuals > 3 > balance Sheet > long Term Debt
2250269918.12
Annuals > 3 > balance Sheet > total Liabilities
7584859851
Annuals > 3 > balance Sheet > equity
11411354455
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
233383425
Annuals > 3 > cash Flow > depreciation
302744701
Annuals > 3 > cash Flow > change In Working Capital
-1125120086.66
Annuals > 3 > cash Flow > cash From Operations
-6629319.8
Annuals > 3 > cash Flow > capital Expenditures
193860672.46
Annuals > 3 > cash Flow > cash From Investing
719928130
Annuals > 3 > cash Flow > cash From Financing
-501080665.12
Annuals > 3 > cash Flow > net Change In Cash
149388178
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.164102910743985
Annuals > 3 > ratios > PB
0.06038216586081849
Annuals > 3 > ratios > ROE
2.1100700968454844
Annuals > 3 > ratios > ROA
1.2601285818664418
Annuals > 3 > ratios > FCF
-200489992.26000002
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-0.0314979421697926
Annuals > 3 > health Score
47
Valuation > metrics > PE
0.18074743182986333
Valuation > metrics > PB
0.05667909909015947
Valuation > final Score
90
Valuation > verdict
96.3% Undervalued
Profitability > metrics > ROE
2.181559113921777
Profitability > metrics > ROA
2.788042670676152
Profitability > metrics > Net Margin
0.186396486990012
Profitability > final Score
41
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.41310266140579793
Risk > metrics > Interest Coverage
17.415647580864245
Risk > final Score
100
Risk > verdict
Low
Liquidity > metrics > Current Ratio
4.392733422315979
Liquidity > metrics > Quick Ratio
2.2364285281967504
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
70
Prev Valuations > 2
90
Prev Profitabilities > 0
24
Prev Profitabilities > 1
0
Prev Profitabilities > 2
19
Prev Risks > 0
92
Prev Risks > 1
39
Prev Risks > 2
76
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:33:42.105Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.0125
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.025
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.0147
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0126
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.0111
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.0479
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
0.0147
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.0873
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
0.0019
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
0.0055
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
0.0066
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-29
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
CNY
Earnings History > 11 > eps Actual
0.05
Earnings History > 11 > eps Estimate
0.02
Earnings History > 11 > eps Difference
0.03
Earnings History > 11 > surprise Percent
150
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-09-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
0.014
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-29
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
CNY
Earnings History > 13 > eps Actual
0.18
Earnings History > 13 > eps Estimate
0.14
Earnings History > 13 > eps Difference
0.04
Earnings History > 13 > surprise Percent
28.5714
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-03-31
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
0.0252
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-30
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
CNY
Earnings History > 15 > eps Actual
-0.05
Earnings History > 15 > eps Estimate
-0.07
Earnings History > 15 > eps Difference
0.02
Earnings History > 15 > surprise Percent
28.5714
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-09-30
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
0.013
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-26
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
CNY
Earnings History > 17 > eps Actual
0.013
Earnings History > 17 > eps Estimate
0.18
Earnings History > 17 > eps Difference
-0.167
Earnings History > 17 > surprise Percent
-92.7778
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-04-28
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
CNY
Earnings History > 18 > eps Actual
0.0206
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0.0206
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-29
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
BeforeMarket
Earnings History > 19 > currency
CNY
Earnings History > 19 > eps Actual
0.21
Earnings History > 19 > eps Estimate
0.17
Earnings History > 19 > eps Difference
0.04
Earnings History > 19 > surprise Percent
23.5294
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-10-29
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
CNY
Earnings History > 20 > eps Actual
0.09
Earnings History > 20 > eps Estimate
0.14
Earnings History > 20 > eps Difference
-0.05
Earnings History > 20 > surprise Percent
-35.7143
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-28
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
CNY
Earnings History > 21 > eps Actual
0.26
Earnings History > 21 > eps Estimate
0.17
Earnings History > 21 > eps Difference
0.09
Earnings History > 21 > surprise Percent
52.9412
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-23
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
CNY
Earnings History > 22 > eps Actual
0.037
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0.037
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
CNY
Earnings History > 23 > eps Actual
0.0289
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0.0289
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
CNY
Earnings History > 24 > eps Actual
0.0447
Earnings History > 24 > eps Estimate
0
Earnings History > 24 > eps Difference
0.0447
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
CNY
Earnings History > 25 > eps Actual
0.014
Earnings History > 25 > eps Estimate
0
Earnings History > 25 > eps Difference
0.014
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-06-30
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
CNY
Earnings History > 26 > eps Actual
0.0046
Earnings History > 26 > eps Estimate
0
Earnings History > 26 > eps Difference
0.0046
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-31
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
CNY
Earnings History > 27 > eps Actual
0.0606
Earnings History > 27 > eps Estimate
0
Earnings History > 27 > eps Difference
0.0606
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-09-30
Earnings History > 28 > report Date
2018-12-31
Earnings History > 28 > date
2018-09-30
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
CNY
Earnings History > 28 > eps Actual
0.0164
Earnings History > 28 > eps Estimate
0
Earnings History > 28 > eps Difference
0.0164
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-06-30
Earnings History > 29 > report Date
2018-09-30
Earnings History > 29 > date
2018-06-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
CNY
Earnings History > 29 > eps Actual
0.0241
Earnings History > 29 > eps Estimate
0
Earnings History > 29 > eps Difference
0.0241
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-03-31
Earnings History > 30 > report Date
2018-06-30
Earnings History > 30 > date
2018-03-31
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
CNY
Earnings History > 30 > eps Actual
0.0212
Earnings History > 30 > eps Estimate
0
Earnings History > 30 > eps Difference
0.0212
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2017-12-31
Earnings History > 31 > report Date
2018-03-31
Earnings History > 31 > date
2017-12-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
CNY
Earnings History > 31 > eps Actual
0.0088
Earnings History > 31 > eps Estimate
0
Earnings History > 31 > eps Difference
0.0088
Earnings History > 31 > surprise Percent
-
Earnings History > 32 > period
2017-09-30
Earnings History > 32 > report Date
2017-12-31
Earnings History > 32 > date
2017-09-30
Earnings History > 32 > before After Market
-
Earnings History > 32 > currency
CNY
Earnings History > 32 > eps Actual
0.014
Earnings History > 32 > eps Estimate
0
Earnings History > 32 > eps Difference
0.014
Earnings History > 32 > surprise Percent
-
Earnings History > 33 > period
2017-06-30
Earnings History > 33 > report Date
2017-09-30
Earnings History > 33 > date
2017-06-30
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
CNY
Earnings History > 33 > eps Actual
0.0095
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
0.0095
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2017-03-31
Earnings History > 34 > report Date
2017-06-30
Earnings History > 34 > date
2017-03-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
CNY
Earnings History > 34 > eps Actual
0.0019
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
0.0019
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2016-12-31
Earnings History > 35 > report Date
2017-03-31
Earnings History > 35 > date
2016-12-31
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
CNY
Earnings History > 35 > eps Actual
-0.0014
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
-0.0014
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2016-09-30
Earnings History > 36 > report Date
2016-12-31
Earnings History > 36 > date
2016-09-30
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
CNY
Earnings History > 36 > eps Actual
0.011
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
0.011
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2016-06-30
Earnings History > 37 > report Date
2016-09-30
Earnings History > 37 > date
2016-06-30
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
CNY
Earnings History > 37 > eps Actual
0.0045
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
0.0045
Earnings History > 37 > surprise Percent
-
Earnings History > 38 > period
2016-03-31
Earnings History > 38 > report Date
2016-06-30
Earnings History > 38 > date
2016-03-31
Earnings History > 38 > before After Market
-
Earnings History > 38 > currency
CNY
Earnings History > 38 > eps Actual
0.0079
Earnings History > 38 > eps Estimate
0
Earnings History > 38 > eps Difference
0.0079
Earnings History > 38 > surprise Percent
-
Earnings History > 39 > period
2015-12-31
Earnings History > 39 > report Date
2016-03-31
Earnings History > 39 > date
2015-12-31
Earnings History > 39 > before After Market
-
Earnings History > 39 > currency
CNY
Earnings History > 39 > eps Actual
0.0243
Earnings History > 39 > eps Estimate
0
Earnings History > 39 > eps Difference
0.0243
Earnings History > 39 > surprise Percent
-
Earnings History > 40 > period
2015-09-30
Earnings History > 40 > report Date
2015-12-31
Earnings History > 40 > date
2015-09-30
Earnings History > 40 > before After Market
-
Earnings History > 40 > currency
CNY
Earnings History > 40 > eps Actual
0.0196
Earnings History > 40 > eps Estimate
0
Earnings History > 40 > eps Difference
0.0196
Earnings History > 40 > surprise Percent
-
Earnings History > 41 > period
2015-06-30
Earnings History > 41 > report Date
2015-09-30
Earnings History > 41 > date
2015-06-30
Earnings History > 41 > before After Market
-
Earnings History > 41 > currency
CNY
Earnings History > 41 > eps Actual
0.0189
Earnings History > 41 > eps Estimate
0
Earnings History > 41 > eps Difference
0.0189
Earnings History > 41 > surprise Percent
-
Earnings History > 42 > period
2015-03-31
Earnings History > 42 > report Date
2015-06-30
Earnings History > 42 > date
2015-03-31
Earnings History > 42 > before After Market
-
Earnings History > 42 > currency
CNY
Earnings History > 42 > eps Actual
0.0109
Earnings History > 42 > eps Estimate
0
Earnings History > 42 > eps Difference
0.0109
Earnings History > 42 > surprise Percent
-
Earnings History > 43 > period
2014-12-31
Earnings History > 43 > report Date
2015-03-31
Earnings History > 43 > date
2014-12-31
Earnings History > 43 > before After Market
-
Earnings History > 43 > currency
CNY
Earnings History > 43 > eps Actual
0.0232
Earnings History > 43 > eps Estimate
0
Earnings History > 43 > eps Difference
0.0232
Earnings History > 43 > surprise Percent
-
Earnings History > 44 > period
2014-09-30
Earnings History > 44 > report Date
2014-12-31
Earnings History > 44 > date
2014-09-30
Earnings History > 44 > before After Market
-
Earnings History > 44 > currency
CNY
Earnings History > 44 > eps Actual
0.0144
Earnings History > 44 > eps Estimate
0
Earnings History > 44 > eps Difference
0.0144
Earnings History > 44 > surprise Percent
-
Earnings History > 45 > period
2014-06-30
Earnings History > 45 > report Date
2014-09-30
Earnings History > 45 > date
2014-06-30
Earnings History > 45 > before After Market
-
Earnings History > 45 > currency
CNY
Earnings History > 45 > eps Actual
0.0143
Earnings History > 45 > eps Estimate
0
Earnings History > 45 > eps Difference
0.0143
Earnings History > 45 > surprise Percent
-
Earnings History > 46 > period
2014-03-31
Earnings History > 46 > report Date
2014-06-30
Earnings History > 46 > date
2014-03-31
Earnings History > 46 > before After Market
-
Earnings History > 46 > currency
CNY
Earnings History > 46 > eps Actual
0.005
Earnings History > 46 > eps Estimate
0
Earnings History > 46 > eps Difference
0.005
Earnings History > 46 > surprise Percent
-
Earnings History > 47 > period
2013-12-31
Earnings History > 47 > report Date
2014-03-31
Earnings History > 47 > date
2013-12-31
Earnings History > 47 > before After Market
-
Earnings History > 47 > currency
CNY
Earnings History > 47 > eps Actual
0.0091
Earnings History > 47 > eps Estimate
0
Earnings History > 47 > eps Difference
0.0091
Earnings History > 47 > surprise Percent
-
Earnings History > 48 > period
2013-09-30
Earnings History > 48 > report Date
2013-12-31
Earnings History > 48 > date
2013-09-30
Earnings History > 48 > before After Market
-
Earnings History > 48 > currency
CNY
Earnings History > 48 > eps Actual
0.0035
Earnings History > 48 > eps Estimate
0
Earnings History > 48 > eps Difference
0.0035
Earnings History > 48 > surprise Percent
-
Earnings History > 49 > period
2013-06-30
Earnings History > 49 > report Date
2013-09-30
Earnings History > 49 > date
2013-06-30
Earnings History > 49 > before After Market
-
Earnings History > 49 > currency
CNY
Earnings History > 49 > eps Actual
0.0051
Earnings History > 49 > eps Estimate
0
Earnings History > 49 > eps Difference
0.0051
Earnings History > 49 > surprise Percent
-
Earnings History > 50 > period
2013-03-31
Earnings History > 50 > report Date
2013-06-30
Earnings History > 50 > date
2013-03-31
Earnings History > 50 > before After Market
-
Earnings History > 50 > currency
CNY
Earnings History > 50 > eps Actual
0.0142
Earnings History > 50 > eps Estimate
0
Earnings History > 50 > eps Difference
0.0142
Earnings History > 50 > surprise Percent
-
Earnings History > 51 > period
2012-12-31
Earnings History > 51 > report Date
2013-03-31
Earnings History > 51 > date
2012-12-31
Earnings History > 51 > before After Market
-
Earnings History > 51 > currency
CNY
Earnings History > 51 > eps Actual
0.0171
Earnings History > 51 > eps Estimate
0
Earnings History > 51 > eps Difference
0.0171
Earnings History > 51 > surprise Percent
-
Earnings History > 52 > period
2012-09-30
Earnings History > 52 > report Date
2012-12-31
Earnings History > 52 > date
2012-09-30
Earnings History > 52 > before After Market
-
Earnings History > 52 > currency
CNY
Earnings History > 52 > eps Actual
0.018
Earnings History > 52 > eps Estimate
0
Earnings History > 52 > eps Difference
0.018
Earnings History > 52 > surprise Percent
-
Earnings History > 53 > period
2012-06-30
Earnings History > 53 > report Date
2012-09-30
Earnings History > 53 > date
2012-06-30
Earnings History > 53 > before After Market
-
Earnings History > 53 > currency
CNY
Earnings History > 53 > eps Actual
0.0189
Earnings History > 53 > eps Estimate
0
Earnings History > 53 > eps Difference
0.0189
Earnings History > 53 > surprise Percent
-
Earnings History > 54 > period
2012-03-31
Earnings History > 54 > report Date
2012-06-30
Earnings History > 54 > date
2012-03-31
Earnings History > 54 > before After Market
-
Earnings History > 54 > currency
CNY
Earnings History > 54 > eps Actual
0.0187
Earnings History > 54 > eps Estimate
0
Earnings History > 54 > eps Difference
0.0187
Earnings History > 54 > surprise Percent
-
Earnings History > 55 > period
2011-12-31
Earnings History > 55 > report Date
2012-03-31
Earnings History > 55 > date
2011-12-31
Earnings History > 55 > before After Market
-
Earnings History > 55 > currency
CNY
Earnings History > 55 > eps Actual
0.0218
Earnings History > 55 > eps Estimate
0
Earnings History > 55 > eps Difference
0.0218
Earnings History > 55 > surprise Percent
-
Earnings History > 56 > period
2011-09-30
Earnings History > 56 > report Date
2011-12-31
Earnings History > 56 > date
2011-09-30
Earnings History > 56 > before After Market
-
Earnings History > 56 > currency
CNY
Earnings History > 56 > eps Actual
0.0137
Earnings History > 56 > eps Estimate
0
Earnings History > 56 > eps Difference
0.0137
Earnings History > 56 > surprise Percent
-
Earnings History > 57 > period
2011-06-30
Earnings History > 57 > report Date
2011-09-30
Earnings History > 57 > date
2011-06-30
Earnings History > 57 > before After Market
-
Earnings History > 57 > currency
CNY
Earnings History > 57 > eps Actual
0.0186
Earnings History > 57 > eps Estimate
0
Earnings History > 57 > eps Difference
0.0186
Earnings History > 57 > surprise Percent
-
Earnings History > 58 > period
2011-03-31
Earnings History > 58 > report Date
2011-06-30
Earnings History > 58 > date
2011-03-31
Earnings History > 58 > before After Market
-
Earnings History > 58 > currency
CNY
Earnings History > 58 > eps Actual
0.0251
Earnings History > 58 > eps Estimate
0
Earnings History > 58 > eps Difference
0.0251
Earnings History > 58 > surprise Percent
-
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. provides pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. It operates in four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization (CDMO), and Others. The company offers finished dose pharmaceutical products, such as prolongin, inhixa, neoparin, and heparin and enoxaparin sodium injections; API products, including heparin and enoxaparin sodium APIs; and pancreatin API. It also provides molecule biologics CDMO services, which include research and development, manufacturing, quality management, and program management services, as well as technical support services. In addition, the company develops apabetalone (RVX-208), a BET bromodomain protein inhibitor in Phase 3 trial to reduce major adverse cardiovascular events, as well as in Phase 2 trial for diabetic nephropathy and fatty disease; oregovomab, a monoclonal antibody in Phase 3 trial for ovarian cancer, as well as in Phase 2 for pancreatic cancer; tosatoxumab (AR-301), a fully human IgG1 monoclonal antibody in Phase 3 trial for ventilator-associated pneumonia; AR20.5 in Phase 2 trial for pancreatic cancer; AR-101 in Phase 2 trial for ventilator-associated pneumonia; and H1710, a heparanase inhibitor preparation for solid tumors. Further, it engages in property management, investment management and consulting, biopharmaceutical technology development and consulting, and equity and venture investment activities; provision of services on pharmaceutical related activities; and trading of medical and biopharmaceutical products. The company was formerly known as Shenzhen Hepalink Pharmaceutical Co.,Ltd. and changed its name to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in February 2017. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, the People's Republic of China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Shenzhen Hepalink Pharmaceutical Group Co. Ltd
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.0125
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.